MYHAVEN

Serial Number 98092131
730

Registration Progress

Application Filed
Jul 19, 2023
Under Examination
Aug 6, 2024
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Aug 06, 2025 21 days

Trademark Image

MYHAVEN

Basic Information

Serial Number
98092131
Filing Date
July 19, 2023
Published for Opposition
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jan 14, 2025
Application
Pending
Classes
016 035 036 044

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
Ritter House, P.O. Box 173
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
Road Town, Tortola VG

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
21 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 06, 2025
Extension Available
Until August 06, 2025

Application History

27 events
Date Code Type Description Documents
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 14, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 6, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 8, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 8, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 8, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 8, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 6, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 6, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 6, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 16, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 15, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 12, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 23, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Printed publications in the nature of brochures, pamphlets, and written articles for medical information and patient support in the field of neurological and neuropsychiatric diseases and disorders
Class 035
Business administration of medication reimbursement programs and services in the field of neurological and neuropsychiatric diseases and disorders; Business administration of patient reimbursement programs in the field of neurological and neuropsychiatric diseases and disorders; Business administration of pharmacy reimbursement programs and services in the field of neurological and neuropsychiatric diseases and disorders
Class 036
Providing a website featuring financial information about medical benefits and reimbursements available for pharmaceuticals in the field of neurological and neuropsychiatric diseases and disorders; providing online information and financial assistance with insurance benefits and coverage for healthcare providers and patients in the field of neurological and neuropsychiatric diseases and disorders; providing information about insurance coverage and reimbursement for prescription drugs in the field of neurological and neuropsychiatric diseases and disorders; financial administration of a patient assistance program for providing pharmaceuticals for neurological and neuropsychiatric diseases and disorders
Class 044
Providing educational and medical information for patients and healthcare providers in the field of neurological and neuropsychiatric diseases and disorders

Additional Information

Pseudo Mark
MY HAVEN

Classification

International Classes
016 035 036 044